Home » Topics » Regulatory » Patents

Patents
RSS

New PROTACs synthesized by C4 Therapeutics

Nov. 4, 2020

Tenaya Therapeutics presents AAV5 compositions

Nov. 4, 2020

Nuvation Bio describes new Wee1 inhibitors

Nov. 4, 2020

Bristol Myers Squibb identifies new Gal-3 inhibitors

Nov. 4, 2020

Plexxikon discloses KAT3B and CREBBP inhibitors

Nov. 4, 2020

Nurix Therapeutics patents CBLB inhibitors

Nov. 4, 2020

Azitra discovers recombinant microorganisms for treating atopic dermatitis

Nov. 3, 2020

Sichuan Kelun-Biotech Biopharmaceutical synthesizes USP7 inhibitors

Nov. 3, 2020

Peloton Therapeutics identifies RBM39 degradation inducers

Nov. 3, 2020

Rottapharm Biotech discloses new DDR2 inhibitors

Nov. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...